A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare records
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Background: Electronic healthcare records (EHRs) are a useful resource to study chronic kidney disease (CKD) progression prior to starting dialysis, but pose methodological challenges as kidney function tests are not done on everybody, nor are tests evenly spaced. We sought to review previous research of CKD progression using renal function tests in EHRs, investigating methodology used and investigators’ recognition of data quality issues. Methods and findings: We searched for studies investigating CKD progression using EHRs in 4 databases (Medline, Embase, Global Health and Web of Science) available as of August 2021. Of 80 articles eligible for review, 59 (74%) were published in the last 5.5 years, mostly using EHRs from the UK, USA and East Asian countries. 33 articles (41%) studied rates of change in eGFR, 23 (29%) studied changes in eGFR from baseline and 15 (19%) studied progression to binary eGFR thresholds. Sample completeness data was available in 44 studies (55%) with analysis populations including less than 75% of the target population in 26 studies (33%). Losses to follow-up went unreported in 62 studies (78%) and 11 studies (14%) defined their cohort based on complete data during follow up. Methods capable of handling data quality issues and other methodological challenges were used in a minority of studies. Conclusions: Studies based on renal function tests in EHRs may have overstated reliability of findings in the presence of informative missingness. Future renal research requires more explicit statements of data completeness and consideration of i) selection bias and representativeness of sample to the intended target population, ii) ascertainment bias where follow-up depends on risk, and iii) the impact of competing mortality. We recommend that renal progression studies should use statistical methods that take into account variability in renal function, informative censoring and population heterogeneity as appropriate to the study question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Previous studies have also shown that reproducibility failures can occur at every stage of the SR process 20-24 .”
From Automation of Systematic Reviews with Large Language Models (2025) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603 · cited 1×
“Such creatininebased GFR-estimating equations are imprecise, particularly at high levels of eGFR [8, 9].”
Backgroundvon Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Benchimol, E. I., Smeeth, L., Guttmann, A., Harron, K., Moher, D., Petersen, I., Sørensen, H. T., von Elm, E., Langan, S. M., & RECORD Working Committee (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001885 · Cited by 5,749 · cited 1×
“Observational studies using EHRs should follow the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) [66, 67] and REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) [68] guidelines, which aim to improve transparency and clarity in reporting of resear…”
MethodDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030 · cited 1×
“Chronic kidney disease (CKD) is a growing public health problem [1, 2].”
BackgroundVandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.07.014 · Cited by 2,969
Evolving importance of kidney disease: from subspecialty to global health burden
Eckardt, K.-U., Coresh, J., Devuyst, O., Johnson, R. J., Köttgen, A., Levey, A. S., & Levin, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60439-0 · Cited by 1,159 · cited 1×
“Chronic kidney disease (CKD) is a growing public health problem [1, 2].”
BackgroundLevey, A. S., Inker, L. A., Matsushita, K., Greene, T., Willis, K., Lewis, E., de Zeeuw, D., Cheung, A. K., & Coresh, J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.030 · Cited by 620 · cited 2×
“In 2012, the United States Food and Drug Administration (FDA) commissioned research to identify new endpoints of CKD progression for use in clinical trials [64, 65].”
BackgroundMethodEriksen, B. O., & Ingebretsen, O. C. (2006) · Kidney International · doi:10.1038/sj.ki.5000058 · Cited by 576
Longitudinal Progression Trajectory of GFR Among Patients With CKD
Li, L., Astor, B. C., Lewis, J., Hu, B., Appel, L. J., Lipkowitz, M. S., Toto, R. D., Wang, X., Wright, J. T., & Greene, T. H. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.12.009 · Cited by 320 · cited 1×
“Severity of disease, mechanism of renal damage and rate of progression of disease vary between patients, and the disease may change course over time in response to changing risk factors [4, 5].”
BackgroundGallant, J. E., Parish, M. A., Keruly, J. C., & Moore, R. D. (2005) · Clinical Infectious Diseases · doi:10.1086/428840 · Cited by 302 · cited 1×
“[38] 2005 1 year 658 Descriptive results only”
BackgroundRenal Outcomes in Anticoagulated Patients With Atrial Fibrillation
Yao, X., Tangri, N., Gersh, B. J., Sangaralingham, L. R., Shah, N. D., Nath, K. A., & Noseworthy, P. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1087 · Cited by 248 · cited 1×
“[30] 2017 11 months 9,796 Cox PH regression”
BackgroundSerum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review
Tsai, C.-W., Lin, S.-Y., Kuo, C.-C., & Huang, C.-C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170393 · Cited by 183
Singh, A., Nadkarni, G., Gottesman, O., Ellis, S. B., Bottinger, E. P., & Guttag, J. V. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.005 · Cited by 136 · cited 1×
“[21] 2015 1 year 6,435 Logistic regression”
Perotte, A., Ranganath, R., Hirsch, J. S., Blei, D., & Elhadad, N. (2015) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv024 · Cited by 128 · cited 1×
“[46] 2015 Not stated 2,908 Cox proportional hazards regression”
BackgroundInternational consensus definitions of clinical trial outcomes for kidney failure: 2020
Levin, A., Agarwal, R., Herrington, W. G., Heerspink, H. L., Mann, J. F. E., Shahinfar, S., Tuttle, K. R., Donner, J.-A., Jha, V., Nangaku, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.013 · Cited by 125 · cited 2×
“In 2012, the United States Food and Drug Administration (FDA) commissioned research to identify new endpoints of CKD progression for use in clinical trials [64, 65].”
BackgroundMethodChakera, A., MacEwen, C., Bellur, S. S., Chompuk, L.-O., Lunn, D., & Roberts, I. S. D. (2016) · Journal of Nephrology · doi:10.1007/s40620-015-0227-8 · Cited by 92 · cited 1×
“[44] 2015 7 years 147 Logistic regression”
Robinson, D. E., Ali, M. S., Pallarés, N., Tebé, C., Elhussein, L., Abrahamsen, B., Arden, N., Ben‐Shlomo, Y., Caskey, F. J., Cooper, C. C., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4235 · Cited by 89
Neuen, B. L., Weldegiorgis, M. T., Herrington, W. G., Ohkuma, T., Smith, M. C., & Woodward, M. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.02.335 · Cited by 71
Patterns of progression of chronic kidney disease at later stages
Caravaca‐Fontán, F., Azevedo, L. M. O., Luna, E., & Caravaca, F. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx083 · Cited by 58 · cited 1×
“Severity of disease, mechanism of renal damage and rate of progression of disease vary between patients, and the disease may change course over time in response to changing risk factors [4, 5].”
BackgroundBleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation
Jackevicius, C. A., Lu, L., Ghaznavi, Z., & Warner, A. L. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.007230 · Cited by 57
Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD
Shou, H., Hsu, J. Y., Xie, D., Yang, W. P., Roy, J. A., Anderson, A. H., Landis, J. R., Feldman, H. I., Parsa, A., Jepson, C., et al. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11311116 · Cited by 54 · cited 1×
“There are a number of methodological challenges in longitudinal analysis of renal function that are not necessarily specific to EHRs but that are important considerations for researchers, discussed in more detail in [10, 63] and introduced earlier.”
BackgroundNichols, G. A., Déruaz‐Luyet, A., Brodovicz, K. G., Kimes, T. M., Rosales, A. G., & Hauske, S. J. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01792-y · Cited by 53 · cited 1×
“[50] 2020 5 years Approx 37,000 Life-table analysis”
Cabrera, C. S., Lee, A. S., Olsson, M., Schnecke, V., Westman, K., Lind, M., Greasley, P. J., & Skrtic, S. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.07.029 · Cited by 51
Real-time monitoring of progression towards renal failure in primary care patients
Diggle, P. J., Sousa, I., & Asar, O. (2015) · Biostatistics · doi:10.1093/biostatistics/kxu053 · Cited by 50
Evans, R. D. R., Cargill, T. N., Goodchild, G., Oliveira, B., Rodriguez‐Justo, M., Pepper, R. J., Connolly, J. O., Salama, A. D., Webster, G. J. M., Barnes, E. J., et al. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.08.011 · Cited by 50 · cited 1×
“[22] 2018 5 years 24 Descriptive result only”
BackgroundRenal biopsy in liver transplant recipients
O’Riordan, A., Dutt, N., Cairns, H., Rela, M., O’Grady, J. G., Heaton, N. D., & Hendry, B. M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp112 · Cited by 45
Boucquemont, J., Heinze, G., Jager, K. J., Oberbauer, R. W., & Leffondré, K. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-45 · Cited by 44
Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England
Horne, L., Ashfaq, A., MacLachlan, S., Sinsakul, M. V., Qin, L., LoCasale, R. J., & Wetmore, J. B. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1250-0 · Cited by 41
Butt, A. A., Ren, Y., Puenpatom, A., Arduino, J. M., Kumar, R. N., & Abou‐Samra, A. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14799 · Cited by 40 · cited 1×
“[20] 2018 3 months 17,624 Difference in proportions chisquared test”
BackgroundTangri, N., Reaven, N. L., Funk, S. E., Ferguson, T. W., Collister, D., & Mathur, V. S. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02385-z · Cited by 38
Leither, M. D., Murphy, D. P., Bicknese, L., Reule, S. A., Vock, D. M., Ishani, A., Foley, R. N., & Drawz, P. E. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy036 · Cited by 37
UK Renal Registry 20th Annual Report: Introduction
Evans, K., Pyart, R., Steenkamp, R. D., Whitlock, T., Stannard, C., Gair, R., McCann, J., Slevin, J., Medcalf, J. F., & Caskey, F. J. (2018) · The Nephron journals/Nephron journals · doi:10.1159/000490958 · Cited by 34
Progressive chronic kidney disease in primary care: Modifiable risk factors and predictive model
Herget‐Rosenthal, S., Dehnen, D., Kribben, A., & Quellmann, T. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.06.010 · Cited by 33
Li, X. M., Rui, H., Liang, D., Xu, F., Liang, S. S., Zhu, X. D., Huang, X. H., Liu, Z. H., & Zeng, C. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2659-1 · Cited by 33
Lin, Y., Lai, Y., Lin, Y., Peng, C., Chen, K., Chuang, M., Wu, K., & Chang, T. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12423 · Cited by 33
Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation
VanWagner, L. B., Montag, S., Zhao, L., Allen, N. B., Lloyd-Jones, D. M., Das, A., Skaro, A. I., Hohmann, S., Friedewald, J. J., & Levitsky, J. (2018) · Transplantation · doi:10.1097/tp.0000000000002175 · Cited by 32
Epidemiological Study of Chronic Kidney Disease Progression
Vejakama, P., Ingsathit, A., Attia, J., & Thakkinstian, A. (2015) · Medicine · doi:10.1097/md.0000000000000475 · Cited by 31
Impact of Uric Acid Levels on Kidney Disease Progression
Rincon-Choles, H., Jolly, S. E., Arrigain, S., König, V., Schold, J. D., Nakhoul, G., Navaneethan, S. D., Nally, J. V., & Rothberg, M. B. (2017) · American Journal of Nephrology · doi:10.1159/000481460 · Cited by 31
Inaguma, D., Kitagawa, A., Yanagiya, R., Koseki, A., Iwamori, T., Kudo, M., & Yuzawa, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239262 · Cited by 31 · cited 1×
“[28] 2020 2 years 9,911 Logistic regression; Random forest regression”
BackgroundLv, L., Chang, D., Li, Z., Chen, M., Hu, Z., & Zhao, M. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0763-7 · Cited by 30
Peng, Y.-L., Tain, Y., Lee, C., Yang, Y., Huang, Y., Wen, Y.-H., & Hsu, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-67026-1 · Cited by 30
Cummings, D. M., Larsen, L. C., Doherty, L., Lea, C. S., & Holbert, D. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.04.100186 · Cited by 28
Posch, F., Ay, C., Stöger, H., Kreutz, R. H., & Beyer‐Westendorf, J. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12189 · Cited by 28
Weldegiorgis, M., Smith, M. C., Herrington, W., Bankhead, C., & Woodward, M. (2019) · Nephrology, Dialysis and Transplantation · doi:10.1093/ndt/gfz059 · Cited by 28
Nichols, G. A., Déruaz‐Luyet, A., Brodovicz, K. G., Kimes, T. M., Rosales, A. G., & Hauske, S. J. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01854-1 · Cited by 28
Eriksen, B. O., Tomtum, J., & Ingebretsen, O. C. (2010) · Nephron Clinical Practice · doi:10.1159/000286349 · Cited by 26
Viazzi, F. C., Greco, E., Ceriello, A., Fioretto, P., Giorda, C. B., Guida, P., Russo, G. T., Cosmo, S. D., Pontremoli, R., & AMD-Annals Study Group (2018) · Kidney & Blood Pressure Research · doi:10.1159/000488255 · Cited by 26 · cited 1×
“[32] 2018 4 years 535 Logistic regression”
Rej, S., Herrmann, N., Gruneir, A., McArthur, E., Jeyakumar, N., Muanda, F. T., Harel, Z., Dixon, S., & Garg, A. X. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19m13045 · Cited by 26
Wang, Y., Zhao, L., Zhang, J., Wu, Y., Zhang, R., Li, H., Guo, R., Han, Q., Wang, T., Li, L., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00855 · Cited by 24 · cited 1×
“[12] 2019 2 years 128 Logistic regression”
Niu, S., Wu, C., Chuang, N.-C., Yang, Y.-B., & Chang, T. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041210 · Cited by 24
The impact of acute kidney injury in diabetes mellitus
Johnson, F., Phillips, D., Talabani, B., Wonnacott, A., Meran, S., & Phillips, A. O. (2015) · Nephrology · doi:10.1111/nep.12649 · Cited by 23
Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy
Liu, D., You, J., Liu, Y., Tang, X., Tan, X., Xia, M. X., Wu, L., Chen, G., He, L., Zhu, X., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.044 · Cited by 22
Nderitu, P., Doos, L., Strauss, V. Y., Lambie, M., Davies, S. J., & Kadam, U. T. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005581 · Cited by 21 · cited 1×
“[41] 2014 9 months 4,145 Logistic regression”
Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
Lamacchia, O., Viazzi, F. C., Fioretto, P., Mirijello, A., Giorda, C. B., Ceriello, A., Russo, G. T., Guida, P., Pontremoli, R., & Cosmo, S. D. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0361-2 · Cited by 21
Chase, H. S., Hirsch, J. S., Mohan, S., Rao, M. K., & Radhakrishnan, J. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-187 · Cited by 15
Hsu, T., Hsu, C., Wang, S., Huang, C.-C., & Li, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070932 · Cited by 15 · cited 1×
“[27] 2019 5 years 5,046 Cox PH regression”
BackgroundOetjens, M. T., Bush, W. S., Birdwell, K. A., Dilks, H. H., Bowton, E., Denny, J. C., Wilke, R. A., Roden, D. M., & Crawford, D. C. (2013) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814583220_0025 · Cited by 14
Jalal, K., Anand, E. J., Venuto, R. C., Eberle, J., & Arora, P. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1429-4 · Cited by 14
Vesga, J. I., Cepeda, E., Pardo, C. E., Páez, S., Sánchez, R., & Sanabria, M. (2021) · International Journal of Nephrology · doi:10.1155/2021/8866446 · Cited by 13 · cited 1×
“[52] 2021 6-month intervals 1,783 Crude estimation”
Effects of sarpogrelate on microvascular complications with type 2 diabetes
Yoo, H., Park, I., Kim, D. J., & Lee, S. (2019) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-019-00794-7 · Cited by 11
Yanagawa, T., Koyano, K., & Azuma, K. (2021) · Diabetology International · doi:10.1007/s13340-020-00483-1 · Cited by 11
Koraishy, F. M., Hooks-Anderson, D. R., Salas, J., & Scherrer, J. F. (2017) · Family Practice · doi:10.1093/fampra/cmx012 · Cited by 10 · cited 1×
“[42] 2017 Not stated 2,170 Logistic regression”
Renal Function Decline in Latinos With Type 2 Diabetes
Alvarez, M. C. M., Garcia-Dolagaray, G., Millán-Ferro, A., & Rosas, S. E. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.05.012 · Cited by 7 · cited 1×
“[40] 2019 Not stated 594 Descriptive comparisons eGFR drop per time elapsed: > 5 ml/min/1.”
BackgroundLiu, C., Chen, H., Liu, C., Fu, C., Zhang, H., Yang, H., Wang, P., Wang, F., Chen, S., & Ma, Q. (2014) · Journal of Nephrology · doi:10.1007/s40620-013-0011-6 · Cited by 6 · cited 1×
“[45] 2014 3 years 365 Logistic regression”
Annor, F., Masyn, K. E., Okosun, I. S., Roblin, D. W., & Goodman, M. G. (2015) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2015.07.002 · Cited by 5 · cited 1×
“[18] 2015 4 years 575 Structural equation modelling”
BackgroundAbdelhafiz, A. H., Tan, E., Levett, C., Minchin, J., & Nahas, M. E. (2012) · Hospital Practice · doi:10.3810/hp.2012.10.1003 · Cited by 4 · cited 1×
“[13] 2012 14 years 100 Logistic regression”
Cited by
Automation of Systematic Reviews with Large Language Models
Cao, C., Arora, R., Cento, P., Budak, A., Manta, K., Farahani, E., Cecere, M., Selemon, A., Sang, J., Gong, L. X., et al. (2025) · medRxiv · doi:10.1101/2025.06.13.25329541 · Cited by 33
Common mistakes in biostatistics
D’Arrigo, G., ElHafeez, S. A., Mezzatesta, S., Abelardo, D., Provenzano, F., Vilasi, A. D., Torino, C., & Tripepi, G. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae197 · Cited by 22
“Researchers are increasingly turning to routinely collected data from large databases to assess the effectiveness of specific interventions on a certain endpoint such as progression of chronic kidney disease [21 ].”
BackgroundAutomated classification of clinical diagnoses in electronic health records using transformer
Dai, L., Xu, H., & Zhang, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329963 · Cited by 14
“The field employs various computational techniques ranging from traditional statistical methods [38] to advanced machine learning algorithms [39], all designed to process heterogeneous medical data including clinical notes, laboratory results, medication records, and demographic information.”
Iwagami, M., Odani, K., & Saito, T. (2024) · Kidney360 · doi:10.34067/kid.0000000608 · Cited by 4
Retracted: Machine Learning-Based Monitoring and Prognosis of Chronic Kidney Disease Patients
Abhang, S. P., Tarambale, M., Esnaashariyeh, A., Shete, P. G., Jallepalli, V. R., Rai, V., & Prajapati, T. M. (2023) · International Conference on Artificial Intelligence for Innovations in Healthcare Industries (ICAIIHI) · doi:10.1109/icaiihi57871.2023.10489422 · Cited by 1
Retracted
Metadata
- Authors
- Cleary, F., Prieto-Merino, D., & Nitsch, D.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Cleary, Faye
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-07-29
- Volume
- 17
- Issue
- 7
- Pages
- e0264167
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC9337679
- OpenAlex
- W4288692554
- Cited by
- 6
- References
- 71
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 1
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Medical Research Council (MR/N013638/1)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Health Professions › Health Information Management › Medical Coding and Health Information
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Keywords
- chronic kidney disease progression, electronic health records, estimated glomerular filtration rate, missing data, informative censoring, loss to follow-up, selection bias, ascertainment bias, competing risk of death, data quality, statistical methodology
- MeSH terms
- Delivery of Health Care, Electronics, Renal Dialysis, Humans, Reproducibility of Results, Disease Progression, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

